Unclaimed brand
Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#F45B39
Flamingo
244, 91, 57
11, 89, 59
0, 63, 77, 4
#FFCC98
Peach Orange
255, 204, 152
30, 100, 80
0, 20, 40, 0
#272F33
Outer Space
39, 47, 51
200, 13, 18
24, 8, 0, 80
FogPharma is a pioneering brand that is revolutionizing the field of precision medicines. By addressing the limitations of today's medications, FogPharma is striving to achieve universal druggability. Their innovative approach involves the development of a new class of drugs called Helicon™ Polypeptides.
FogPharma's cutting-edge discovery engine combines state-of-the-art technologies to accelerate the speed and scalability of drug discovery. This enables them to advance novel Helicon polypeptide therapeutics that target previously intractable disease areas. These polypeptides offer the combined benefits of antibody-like targeting strength and specificity, as well as the broad tissue distribution, intracellular target engagement, and oral dosing optionality of small molecules.
FogPharma's first-in-class programs are particularly focused on addressing the elusive drivers of cancer. Their team consists of energetic, visionary, relentless, and rebellious individuals who collaborate and strive to push the boundaries of science. If you share a passion for innovative science, FogPharma invites you to join them on their journey to shape the future of precision medicine
Company type
Privately Held
Year founded
2016
Company size
51-200 employees
Alpha-helical peptide therapeutics
Intracellular protein modulation
Β-catenin:TCF inhibitors
Wnt pathway oncology
Undruggable cancer targets
How do I download the Parabilis Medicines logo?
The Parabilis Medicines logo comes in two versions: light logo and dark icon. Download as SVG, transparent PNG or JPEG.
What does Parabilis Medicines' branding look like?
The Parabilis wordmark uses a clean, light sans-serif treatment, with an orange curved motif rising through the lettering and a small MEDICINES descriptor beneath. Its visual identity pairs restrained sans-serif typography with a cool palette of white, gray, and muted charcoal, punctuated by orange and violet; scientific and people-focused photography, handwritten notes, and spacious, layered compositions lend it a human, exploratory character.
What are Parabilis Medicines' brand colors?
The Parabilis Medicines color palette uses the hex codes #F45B39, #FFCC98 and #272F33.
The Parabilis Medicines name, logos and brand assets are trademarks of Parabilis Medicines and its affiliates. Brandfetch isn't affiliated with or endorsed by Parabilis Medicines. Their use is subject to Parabilis Medicines's brand guidelines.
